Introducing Wee Hemp Spirits – You say “It Canna’B”…Wee Say “It Can”…
“We want to break down that stigma and use amazing local produce for the spirits.”
“CBD STRAINS 2018” The SWEET SEEDS® apothecary
I hope you always find space to have some of these plants in your garden. You will not be disappointed.
Breaking News for cancer patients treated with medical cannabis
Panaxia’s advanced medical cannabis products, marketed by Rafa Pharmaceuticals, will be tested as part of the clinical trial and its registration will revolutionize the way medical cannabis is used for treating patients.
Cannabinoids: a new approach for pain control?
To analyze available data related to the use of cannabinoids in medicine, with a special focus on pain management in cancer. The use of cannabis for medical purposes is growing but there are still numerous questions to be solved: effectiveness, safety, and specific indications. The endocannabinoid system is a potential therapeutic target. Cannabinoids may be considered as potential adjuvant in cancer-related pain management.
Plant-derived medicines for neuropathies: a comprehensive review of clinical evidence
Neuropathy is defined as the damage to the peripheral or central nervous system accompanied by pain, numbness, or muscle weakness, which can be due to congenital diseases or environmental factors such as diabetes, trauma, or viral infections. As current treatments are not sufficiently able to control the disease, studies focusing on the identification and discovery of new therapeutic agents are necessary.
Cannabinoid control of neuroinflammation related to multiple sclerosis
The cannabis plant (Cannabis sativa) has been known by many names but the question remains ‘Can we call it medicine?’ There has been renewed interest in the value of cannabis for the control of neuroinflammatory conditions such as multiple sclerosis, where it has been shown to have some effect on spasticity and pain both experimentally and in clinical trials in humans.
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
Multiple sclerosis (MS) is the major immune-mediated, demyelinating, neurodegenerative disease of the central nervous system. Compounds within cannabis, notably Δ9-tetrahydrocannabinol (Δ9-THC) can limit the inappropriate neurotransmissions that cause MS-related problems and medicinal cannabis is now licenced for the treatment of MS symptoms. However, the biology indicates that the endocannabinoid system may offer the potential to control other aspects of disease.
ECH plans first UK-wide network of specialist medical cannabis clinics
The clinics will specialise in innovative cannabis-based therapy and prescription cannabinoids, and be open to patients following specialist referral.
Cannabis in palliative medicine: improving care and reducing opioid-related morbidity
Unlike hospice, long-term drug safety is an important issue in palliative medicine. Opioids may produce significant morbidity. Cannabis is a safer alternative with broad applicability for palliative care. This article provides an evidence-based overview and comparison of cannabis and opioids. Using this foundation, an argument is made for reclassifying cannabis in the context of improving palliative care and reducing opioid-related morbidity.
